Patent, is a legal document
granted by the government giving an inventor the exclusive right to make, use,
and sell an invention for a specified number of years. Patents are also
available for significant improvements on previously invented items.
The goal of the patent
system is to encourage inventors to advance the state of technology by awarding
them special rights to benefit from their inventions. Books, movies, and works
of art cannot be patented, but protection is available for such items under the
law of copyright. Patent law is one branch of the larger legal field known as
intellectual property, which also includes trademark and copyright law.
Patent law centers round the
concept of novelty and inventive step (or lack of obviousness). The right which
they accord is to prevent all others, not just imitators but even independent
devisors of the same idea from using the invention for the duration of the
patent. The special potential of a patent is accordingly that it may be used to
prevent all others from including any form of invention in their product and
services. A patent thus poses serious difficulties for its competitors. This is
why patents are not freely available for all industrial improvements but only
what is judged to qualify as a patentable invention.
What is patentable?
To qualify for a patent, the invention must meet three basic tests. First, it
must be novel, meaning that the invention did not
previously exist. Second, the invention must be non-obvious, which means that
the invention must be a significant improvement to existing technology. Simple
changes to previously known devices do not comprise a patentable invention.
Finally, the proposed invention must be useful. Legal experts commonly interpret
this to mean that no patent will be
granted for inventions that can only be used for an illegal or immoral purpose.
Some types of discoveries
are not patentable. No one can obtain a patent on a law of nature or a
scientific principle even if he or she is the first one to discover it. For
example, Isaac Newton could not have obtained a patent on the laws of gravity,
and Albert Einstein could not have patented his formula for relativity, E=mc2.
Under the law of the
European Patent Convention (EPC), patents are only granted for inventions which
are capable of industrial application, which are new and which involve an
inventive step. An invention may be defined as a proposal for the practical
implementation of an idea for solving a technical problem. An invention is
capable of industrial application if it can be made or used in any kind of
industry, including agriculture, as distinct from purely intellectual or
An invention is said to be
new if, prior to the date of filing or to the priority date accorded to the
application from an earlier application for the same invention, it was not
already known to the public in any form (written, oral or through use), ie it
did not form part of the state of the art. An invention is said to involve an
inventive step if, in the light of what is already known to the public, it is
not obvious to a so-called skilled person, ie someone with good knowledge and
experience of the field.
Under the Indian patent law
a patent can be obtained only for an invention which is new and useful. The
invention must relate to a machine, article or substance produced by
manufacture, or the process of manufacture of an article. A patent may also be
obtained for an improvement of an article or of a process of manufacture. In
regard to medicine or drug and certain classes of chemicals no patent is granted
for the substance itself even if new, but a process of manufacturing and
substance is patentable. The application for a patent must be true and the first
inventor or the person who has derived title from him, the right to apply for a
patent being assignable.
In view of the Office instructions of the Controller General of Patents, Designs
& Trademarks dated 15th July, 1991, view point regarding patentability of
biotechnological inventions in India is:
(1) Inventions relating to
organisms or biological material per se viz.-
(a) living entities of natural or artificial origin such as animals, plants and
microorganisms, biological material such as
plasmids, viruses, gene, recombinant DNA, bacteria, fungi, algae and other
materials having self replicating properties and parts thereof,
(b) Naturally occurring
substances from living entities, biological materials and also process for their
production, are not
Patentable under the Act. Hence no claim is allowable for such inventions.
Inventions relating to process or methods of production of tangible and
nonliving substances like enzymes, antibiotics, insulin, hormones, interferon,
alcohols, vaccines etc. by bioconversion or using such microorganisms or by
utilizing the above referred biologically active substances as well as chemical
substances produced by using genetically engineered organisms or such existing
substances made more economically by use of biotechnology and/or microbiology
are patentable under the Patent Act, 1970.
While claiming the
inventions in respect of above subject where strain/bacteria have been used and
deposited in depositing authorities and allotted their accession number, such
depositions or accession number should be followed by the characteristics of
such strain or bacteria.
Under U.S. law, the person
who first invented the item receives the patent. If it is unclear who invented
the item first, the PTO
decides who gets the patent in a proceeding known as an interference. The losing
party may then appeal the PTOs decision at the Court of Appeals for the Federal
Circuit, a specialized court in Washington, D.C., established to deal with
Under the United States law
4 types of patents can be issued viz., utility, design, plant and provisional:-.
Utility patents may be granted to anyone who invents or discovers any new and
useful process, machine, article of manufacture, or compositions of matters, or
any new useful improvement thereof. Design patents may be granted to anyone who
invents a new, original, and ornamental design for an article of manufacture.
The term of a design patent is 14 years.
Plant patents may be granted to anyone who invents or discovers and asexually
reproduces any distinct and new variety of plant. Plant utility patent
protection is available for biotechnology processes, genes, seeds, plant parts,
cultivates, and hybrids. Utility patents may also be obtained on plants if the
invention is new, useful, and not obvious.
Provisional patents allow
applicants to inexpensively establish an early filing date, or constructive
reduction to practice, for an invention described in the provisional application
without starting the 20 year patent term clock. It can provide up to twelve
months to further develop the invention, determine marketability, acquire
funding or capital, seek licensing or manufacturing.
What is not patentable?
Some inventions cannot be patented. Under the law of the European Patent
Convention (EPC) the list of non-patentable subject-matter includes methods of
medical treatment or diagnosis, and new plant or animal varieties. Further
information on such fields can be obtained from a patent attorney. Nor may
patents be granted for inventions whose exploitation would be contrary to public
order or morality (obvious examples being land-mines or letter-bombs).The
following are not
regarded as inventions: discoveries; scientific theories and mathematical
methods; aesthetic creations, such as works of art or literature; schemes, rules
and methods for performing mental acts, playing games or doing business;
presentations of information; computer software.
Under the Indian law the
following are non patentable (as mentioned under section 3 and 5 of Indian
Patents Act, 1970):-
An invention which is frivolous or which claims anything obvious contrary to
well established natural laws. An invention the primary or intended use of which
would be contrary to law or morality or injurious to public heath. The mere
discovery of a scientific principle or the formulation of an abstract theory.
The mere discovery of any
new property or new use for a known substance or of the mere use of a known
process, machine or apparatus unless such known process results in a new product
or employs at least one new reactant.
A substance obtained by a
mere admixture resulting only in the aggregation of the properties of the
components thereof or a process for producing such substance The mere
arrangement or re-arrangement or duplication of known devices
each functioning independently of one another in a known way. A method or a
process of testing applicable during the process of manufacture for rendering
the machine, apparatus or other equipment more efficient or for the improvement
or restoration of the existing machine, apparatus or other equipment or for the
improvement or control of manufacture.
A method of agriculture or
Any process for the medicinal, surgical, curative, prophylactic or other
treatment of human being or any process for a similar treatment of animals or
plants to render them free of disease or to increase their economic value or
that of their products.
No Patent shall be granted
in respect of an invention relating to Atomic energy. Claiming substances
intended for use, or capable of being used, as food or as medicine or drug
Relating to substance prepared or produced by chemical processes (including
Alloys, optical glass, semiconductor and inter-metallic compounds), no patent
shall be granted in respect of claims for the substances themselves, but claims
for the methods or processes of manufacture shall be patentable. The criteria
under the US laws are also quite similar as above. Books, movies, and works of
art cannot be patented, but protection is available for such items under the law
History of Patents
first patent law was passed by the city of Venice in 1474. It protected the
interests of inventors by assuring them the right to their inventions and
prohibiting unauthorised copying.
In 1624, the Statute of Monopolies was enacted
in England. This allowed patents to be granted for a limited period to the true
and first inventor.
The increasing number of national patent laws led in 1883 to
the conclusion of the Paris Convention, providing a guarantee of equal treatment
for patent applicants in all its member states. It was
originally adopted by 20
countries from around the world and has since been adopted by most
In addition, most of the
worlds nations have signed several other treaties dealing with patent issues
during the 20th century. For example, more than 120 countries have signed the
1994 Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS).
This treaty strengthened legal protection for patents worldwide.
In the United States, patent
law dates to 1641, when the first patents for inventions were issued by the
Massachusetts Bay Colony for the manufacture of salt. The Constitution of the
United States, which became effective in 1789, gave Congress the power to enact
federal patent laws. Congress adopted the first patent law in 1790 as one of its
first actions. It has frequently amended U.S. patent law since then. The current
patent law was adopted in 1952 and is administered by the U.S.
Patent and Trademark Office (PTO), an agency within the Department of Commerce.
Despite the early development of patent law in the United States, there was no
central administrative office to determine the validity of U.S. patents until
the PTO was established in 1836. Since then, the PTO has examined all
applications for patents to decide whether they meet the requirements of the
The Patent Act, 1970 came
into force on 20.4.1972 replacing Indian Patents and Designs Act, 1911. The
Patents Act, 1970 in comparison with Indian Patents and Designs Act, 1911 has
far more reaching effect in some areas such as food, Drug and Medicines where
all the patents granted under this category and deemed to be endorsed with the
words License of Right. India has become a member of the Paris Convention and
PCT w.e.f. 7.12.1998 and by virtue of this, the Head Office of
Patent Office & its Branch offices have become receiving offices for the purpose
of international applications filed under PCT.
In view of these
developments, the Patents Rules, 1972 have been amended by incorporating a new
chapter IIA dealing with international application which can be filed at Head
office of the Patent office at Calcutta or Branch Offices at Delhi, Chennai &
Mumbai w.e.f. 17.11.99 as applicable. The present Act under Chapter IVA provides
specific provisions for the grant of EMR (Exclusive Marketing Rights) with a
view to fulfill its international obligation under the provisions of article
70.8 & 70.9 of TRIPs agreement which are in force w.e.f. 1.1.1995.
A U.S. patent for an invention is the grant of a property right to the
inventor(s), issued by the U.S. Patent and Trademark Office. Despite the early
development of patent law in the United States, there was no central
administrative office to determine the validity of U.S. patents until the PTO
was established in 1836. Since then, the PTO has examined
all applications for patents to decide whether they meet the requirements of the
The right conferred by the
patent grant is, in the language of the statute and of the grant itself, "the
right to exclude others from making, using, offering for sale, or selling" the
invention in the United States or "importing" the invention into the United
To get a U.S. patent, an
application must be filed in the U.S. Patent and Trademark Office. Since June 8,
1995, the United States Patent and Trademark Office (USPTO) has offered
inventors the option of filing a provisional application for patent which was
designed to provide a lower-cost first patent filing in the United States and to
give U.S. applicants parity with foreign applicants under the GATT Uruguay Round
A provisional application
for patent is a U. S. national application for patent filed in the USPTO under
35 U.S.C. §111(b). It
allows filing without a formal patent claim, oath or declaration, or any
information disclosure (prior art) statement. It provides the means to establish
an early effective filing date in a non-provisional patent application filed
under 35 U.S.C. §111(a). It also allows the term "Patent Pending" to be applied.
A non provisional utility patent application must be in the English language or
be accompanied by a verified translation in the English language and a fee set
forth in 37 CFR §1.17(i).
Under the Indian Patents
Act, 1970 sections 73-76 talk about Patent Office.
It is the office along with its branches established to administer various
provisions relating the grant of patent and maintenance of Register of patents
under the Act. The
Head Office of Patent Office
is located at Calcutta and branch offices are located at Mumbai, Delhi & Chennai.
The Patent Office is under
the charge of Controller General of Patents, Designs & Trade Marks who is the
Controller of Patents for the purpose of the Act. The Central Government has
power to specify for the purpose of facilitating the registration of Patents,
the establishment of Head Office and branch offices at the places it may think
fit. The Patent Offices and branch offices shall have seal of Patent Office. The
Patent office and its Branches are having territorial jurisdiction on a
zonal basis as given in the introduction chapter.
Officers and employees of
the Patent Offices, who are in service, are prohibited from requiring, taking
any right or interest in a patent issued by the office directly or indirectly
except by inheritance or bequest. The Officers and employees are also prohibited
from furnishing information on a matter which is being dealt with under the Act
and from assisting in the preparation of a document to be filed in the Patent
Office under the Act or for conducting a search in the Patent office
records except when required or authorized by this Act or under the directions
in writing of Central Government or Controller or by order of a Court.
The European Patent Office (EPO)
grants European patents for the contracting states to the European Patent
Convention (EPC), which was signed in Munich on 5 October 1973 and entered into
force on 7 October 1977. It is the executive arm of the European Patent
Organisation, an intergovernmental body set up under the EPC, whose members are
contracting states. The activities of the EPO are supervised by the
Organisations Administrative Council, composed of delegates from the contracting
The European Patent
Convention (EPC) makes it possible to obtain patent protection in up to 20
European countries on the basis of a single application. The applicant decides
which countries the European patent should cover. European patents are granted
by the European Patent Office (EPO) using a unitary and centralised procedure
conducted in one of its three official languages English, French or German. They
have the same legal effects as national patents in each country for which they
are granted. European patents are cost-effective and time-saving so as to obtain
sound protection in a range of European countries.
Identification of patents
and patent applications.
An assignment relating to a patent must identify the patent by the patent
number. An assignment relating to a national patent application must identify
the national patent application by the application number (consisting of the
series code and the serial number, e.g., 07/123,456). An assignment relating to
an international patent application which designates the United States of
America must identify the international application by the international
application number (e.g., PCT/US90/01234).
If an assignment of a patent
application filed under 1.53(b) is executed concurrently with, or subsequent to,
the execution of the patent application, but before the patent application is
filed, it must identify the patent application by its date of execution, name of
each inventor, and title of the invention so that there can be no mistake as to
the patent application intended. If an assignment of a provisional application
under 1.53(c) is executed before the provisional application is filed, it must
identify the provisional application by name of each inventor and title of the
invention so that there can be no mistake as to the provisional application
The patent or patent
application to which an assignment relates must be identified by patent number
or application number unless the assignment is executed concurrently with or
subsequent to the execution of the application but before the application is
filed. Then, the application must be identified by the date of execution, the
name(s) of the inventors, and the title of the invention. If an assignment of a
provisional application is executed before the provisional application
is filed, it must identify the provisional application by name(s) of the
inventors and the title of the invention.
The Office makes every
effort to provide applicants with the application numbers for newly filed patent
applications as soon as possible. It is suggested, however, that an assignment
be written to allow entry of the identifying number after the execution of the
assignment. An example of acceptable wording is:
"I hereby authorize and
request my attorney, (Insert name), of (Insert address), to insert here in
parentheses (Application number, filed) the filing date and application number
of said application when known."
Filing of Patents
To obtain patent protection in the United States, an inventor must file a patent
application with the PTO. This application has three parts: (1) the
specification, which gives a general description of the invention; (2) the
claims, which provide more detailed statements explaining exactly how the
invention works or is assembled; and (3) drawings that illustrate the invention.
A specially trained official, called a patent examiner, reviews the application
to determine if it qualifies for a patent.
The applicant receives no
patent rights until the PTO approves and issues the patent. During the patent
examination process, the patent examiner may ask the applicant to answer various
questions about the invention. The law requires the patent applicant to disclose
all information in his or her possession that is relevant to whether the patent
should be issued. Because this process often goes back and forth several times
between the applicant and the examiner, a patent examination can be very
time-consuming and the legal fees can be expensive.
A provisional application
for patent has a pendency lasting 12 months from the date the provisional
application is filed. The 12-month pendency period cannot be extended.
Therefore, an applicant who files a provisional application must file a
corresponding non-provisional application for patent during the 12-month
pendency period of the provisional application in order to benefit from the
earlier filing of the provisional application. In accordance with 35 U.S.C.
§119(e), the corresponding non-provisional application must contain or be
amended to contain a specific reference to the provisional application.
However, converting a
provisional application to a non-provisional application (versus filing a
non-provisional application claiming the benefit of the provisional application)
will have a negative impact on patent term. The term of a patent issuing from a
non-provisional application resulting from the conversion of a provisional
application will be measured from the original filing date of the provisional
application. By filing a provisional application first, and then filing a
corresponding non-provisional application that references the provisional
application within the 12-month provisional application pendency period, a
patent term endpoint may be extended by as much as 12 months.
The provisional application
must be made in the name(s) of all of the inventor(s). It can be filed up to one
year following the date of first sale, offer for sale, public use, or
publication of the invention. (These pre-filing disclosures, although protected
in the United States, may preclude patenting in foreign countries.)
A filing date will be
accorded to a provisional application only when it contains:
A written description of the invention, complying with all requirements of 35
U.S.C. §112 ¶ 1 and Any drawings necessary to understand the invention,
complying with 35 U.S.C. §113. If either of these items are missing or
incomplete, no filing date
will be accorded to the provisional application.
To be complete, a
provisional application must also include the filing fee as set forth in 37 C.
F. R. 1.16(k) and a cover sheet
the application as a provisional application for patent;
the name(s) of all inventors;
title of the invention;
name and registration number of attorney or agent and docket number (if
correspondence address; and
any US Government agency that has a property interest in the application.
A non provisional utility patent application must include a specification,
including a claim or claims; drawings, when necessary;
an oath or declaration; and the prescribed filing fee. A complete non
provisional utility patent application should contain the elements listed below:
Utility Patent Application
Transmittal Form or Transmittal Letter
Fee Transmittal Form and Appropriate Fee
Application Data Sheet (see 37 CFR § 1.76)
Specification (with at least one claim)
Drawings (when necessary)
Oath or Declaration
Nucleotide and/or Amino Acid Sequence Listing (when necessary)
If the patent examiner finds that the invention meets the three basic legal
tests viz., novelty, non obviousness and usefulness the PTO will grant a patent.
Under current U.S. law, a patent is valid for 20 years from the date the patent
application is filed. The patent is granted to the individual or individuals who
made the invention. If that person is an employee who did the work as part of a
job, however, the employer has a right to use the invention as well. A patent
only grants rights within the jurisdiction that issued it. Therefore, a U.S.
patent will not provide any rights in other countries.
A patent application becomes
abandoned for failure to file a complete and proper reply as the condition of
the application may require within the time period provided under § 1.134 and §
1.136 unless an Office action indicates otherwise. Abandonment may be either of
the invention or of an application. An abandoned application, in accordance with
37 CFR §§ 1.135 and 1.138, is one which is removed from the Office docket of
pending applications. An application that has been declared abandoned is
and no longer pending.
Abandonment occurs under several circumstances. The most common reason is when
the USPTO does not
receive a response to an Office action letter from an applicant within 6
months from the date the Office action letter was mailed.
The U.S. government grants patents for machines; compositions of
matter, such as new chemical compounds to be used in industry;
manufactured items; and industrial processes, provided they meet a
number of strict legal tests. Patents are also available for significant
improvements on previously invented items. Special patents can be
obtained for the invention or discovery and asexual reproduction of
certain distinct and new types of vegetation.
Patents may also be granted for certain types of industrial
designs, such as a distinct tread pattern on the soles of hiking boots
or tennis shoes. Computer programs have been granted patent protection,
as have various living organisms, such as specialized mice that were
bred to help in cancer research. Books, movies, and works of art cannot
be patented, but protection is available for such items under the law of
Under the law of the European Patent Convention (EPC), patents are
only granted for inventions which are capable of industrial application,
which are new and which involve an inventive step. A European patent can
be granted on the basis of a direct European patent application, which
may be a first filing or, more commonly, one claiming the priority of a
national application filed within the previous 12 months. A European
patent application can also be derived from an international application
filed under the Patent Cooperation Treaty (Euro-PCT application),
either with or without a priority claim.
The Patent Cooperation Treaty (PCT) offers a simplified patent
application procedure for over 100 countries worldwide. It enables
inventors to file a single international application designating many
countries, instead of having to file separately for national or regional
patents. In the international phase, an international search and on
request international preliminary examination is performed. In the
national or regional phase, the patent granting procedure is then
carried out by the relevant national or regional patent offices. As a
regional office, the EPO also grants European patents on the basis of
international applications filed under the PCT.
All the EPC contracting states offer the possibility, as a first
step, of applying for a national patent. Filing a patent application
with a national office gives the advantage of a relatively inexpensive
foot in the door and allows applicants to deal with a patent authority
which is local and speaks their own language. If they decide that they
also need protection in other countries, they then have 12 months to
file applications for the same invention elsewhere and claim the benefit
of the filing date of the first application (priority claim).
European patent applications may be filed either with the European
Patent Office in Munich, The Hague or Berlin, or with national patent
offices in the contracting states. Applicants may, within 12 months of
the date on which a national or European patent application was filed,
claim for the same invention the date of this first application for a
subsequent national or European filing. The application is published 18
months after the date on which the European or national first
application was filed (priority date). The search report is published
either with the application or later on. Applicants then have six months
to decide whether or not to pursue their application by requesting
The three criteria for patentability are novelty, inventive step,
and industrial applicability. If a European patent is granted,
competence is transferred to the designated contracting states, where it
affords the same level of legal protection as a national patent. On
average it takes 44 months to obtain a European patent. Under certain
circumstances more rapid processing is possible at no extra cost. A
European patent is valid for 20 years from the date on which the
application was filed.
Within nine months of the date of grant, any third party may file
opposition against a patent they believe does not comply with the
substantive provisions of the EPC. The EPO opposition division's
decision in such matters holds good in all the contracting states
designated for the patent concerned. Appeals may be lodged against the
decisions of the Receiving Section, the examining divisions and the
opposition divisions. The members of the boards of appeal of the EPO are
impartial, their decisions being governed solely by the provisions of
the EPC. Where necessary, cases may be referred to the Enlarged Board of
Appeal as the body responsible for ensuring uniform application of the
The mission of the EPO is to support innovation, competitiveness
and economic growth for the benefit of the citizens of Europe. Its task
is to grant European patents for inventions, on the basis of a
centralised procedure. By filing a single application in one of the
three official languages (English, French and German) it is possible to
obtain patent protection in some or all of the EPC contracting states.
The European Patent Office (EPO) grants European patents for the
contracting states to the European Patent Convention (EPC), which was
signed in Munich on 5 October 1973 and entered into force on 7 October
1977. It is the executive arm of the European Patent Organisation, an
intergovernmental body set up under the EPC, whose members are the EPC
contracting states. The activities of the EPO are supervised by the
Organisations Administrative Council, composed of delegates from the
The wide-ranging economic significance of patents can be derived
from the fact that patentees can prevent competitors from exploiting
their inventions for up to 20 years. This enables them to recoup their
development costs and gives them enough time to get a fair return on
their investment. Effective patent protection is a stimulus to R&D and a
key requirement for raising venture capital. It fosters technical
innovation, which is crucial to competitiveness and overall economic
In India as per the Patent Act of 1970, an application for a
patent may be made by the actual inventor of the invention, or an
assignee of the right to make an application or a legal representative
of either. It is the person who first applies for a patent who is
entitled to the grant. A prior inventor of the invention who applies
subsequently will not get the patent as against the first applicant. A
person who has merely communicated the idea to another, who actually
gave practical shape to the idea and developed the invention, cannot
claim to be the first and true inventor. A foreign national resident
abroad is not prohibited from making an application and obtaining a
Patent in India.
An application for a patent in the prescribed form along with the
prescribed fee should be filed in appropriate office of the patent
office. An application is required to be filed according to the
territorial limits where the applicant or the first mentioned applicant
in case of joint applicants for a patent normally resides or has
domicile or has a place of business or the place from where the
invention actually originated. If the applicant for the patent or party
in a proceeding having no business places or domicile in India, the
appropriate office will be according to the address of service in India
given by the applicant or party in a proceeding.
Patent Office Branch,
Mumbai- The States of
Gujarat, Goa, Maharashtra,
Madhya Pradesh and the Union Territories of Daman and Diu and Dadra and
Patent Office Branch,
New Delhi- The State of Haryana, Himachal
Pradesh,Jammu& Kashmir, Punjab, Rajasthan, Uttar Pradesh and Delhi and
the Union Territory of Chandigarh.
Patent Office Branch,
Chennai -The States of AndhraPradesh Karnataka,
Kerala, Tamilnadu and Pondicheri and the Union Territories of Laccadive,
Minicoy and Aminidivi Islands.
Patent Office (Head Office),
- Rest of India
The application should be accompanied by a provisional or complete
specification. A provisional specification should describe the invention
only briefly and need not contain the claims. Where the application is
accompanied by a provisional specification, a complete specification
should be filed within 12 months from the date of filing the
application. If this is not done, the application will deemed to be
The complete specification should fully and particularly describe
the invention and the method by which it is to be carried out. It should
disclose the best method of performing the invention known to the
applicant and end with a claim or claims defining the scope of the
invention for which protection is claimed. The claim should relate to
single invention. They should be clear and be fairly based on the matter
disclosed in the specification. The specification should be accompanied
by drawings where appropriate and necessary. The specification should
relate to single invention.
The application is examined by examiners of patents to see whether
it complies with the requirements of the Act and the Rules, whether
there is any lawful ground of objection to the grant of patent, and
whether the invention has already been published or claimed by any other
person. The examiner makes a search in publications available in the
Patent Office and specification of prior applications and Patents to see
whether the same invention has already been published or claimed or is
the subject matter of existing or expired patents.
After examination of the application, the Patent Office will
communicate to the applicant, the objections if any to grant of a
patent. The objections generally relate to the drafting of the
specifications and claims, anticipation of any of the claims in prior
publication of any specification or claims, or documents. In many cases
these objections can be overcome by suitably amending the description of
the invention and the claims and in some cases by insertion of the
reference to the prior specification number. If the objections are not
satisfactorily met, the Controller of Patents, after giving an
opportunity of hearing to the applicant will refuse the application.
Where the application has satisfactorily removed the official
objections the controller will accept the complete specification and
advertise it in the Official Gazette. From the date of acceptance to the
date of sealing of the patent the applicant will get the benefits of the
grant except that he will not be entitled to institute infringement
proceedings until the patents is sealed. Any person interested may give
notice of opposition within three months from the date of advertisement
in the Official Gazette. The Controller will forward the copy a copy of
the notice of opposition to the applicant who may file their evidence in
support of their respective cases and the matter will be heard and
Where an application is accepted either without opposition, a
patent will be granted if a request for sealing is made by the
applicant. An inventor, if he so desires, may make a request for
mentioning his name in the patent. The Controller, if satisfied, will
cause his name to be mentioned as inventor in the patent granted, in the
complete satisfaction and in the register of patents. The mention of the
inventors name in the patent will not confer or derogate from any
rights under the patent.
Under Indian law the term of patent is not the same for all kinds
of invention as in most of other developed countries. In respect of
process patents relating to drugs and fruits, the term is five years
from the date of sealing the patents or seven years from the date of
patent i.e. the date of filing the complete specifications whichever is
shorter. In respect of all other patents the term is 14 years from the
date of patent.
A patent can be kept alive only by paying the renewal fee from
time to time. Also in case of any improvement in or modification of a
previous invention already patented, a patent called patent of
addition may be obtained. The term of the patent of addition will run
concurrently and terminate with the main patent. No renewal fee is
payable so long as the main patent remains in force.
More Articles on Patent:
Patenting of Micro-Organisms in India: Article
27(3)(b) of TRIPS Agreement allows member states to deny patents...
section 2 (j): Invention means a new product or process involving an inventive
Patent & Its Effect In India: Though
India was not a member of Paris convention, but having ......
Challenges to India Patent Regime: The
significance of these rights can be observed by the various upcoming .......
Whether Patent Law Protects Biotechnological Inventions: When
biotechnology and patent law came parallel, again there was controversy.....
Software Patenting: Software
patenting is currently one of the most heated areas of debate,.....
Pharmaceutical Product Patents: A
Patent is a form of Intellectual Property Right granted and protected under the
Patenting Recent Biotechnological Inventions:
Since the discovery of Recombinant DNA technology in the early 1970s,..
Patent Regime And Right To
Gandhi declared India's policy when she said, "idea of a better world is one
Patent Amendment Act, 2005- An Over View: The
intellectual property in India is important at all levels of statutory,
Patents and Geographical Indication: A patent
is a monopoly right granted to person who has invented a new and useful article
Geographical Indication And Basmati:
Intellectual Property is outcome of ones intellect and is different from .....
India In Pharmaceutical Patents Regime: TRIPs,
the intellectual property component of the Uruguay round of the GATT Treaty,
The Patent (Second) Amendment Bill: The Patent
(Second Amendment) Bill 2000 has been proposed by the Govt to bridge the
conflict between the TRIPS and the Patent Act, 1970....
Patenting Of Medicines: global
health crisis is at hand. Millions of people die each year from infectious ...
The ethics of DNA Patenting: biology was
radically transformed by the discovery of the double helical structure of
The author can be reached at :firstname.lastname@example.org